These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
592 related items for PubMed ID: 18029881
41. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Xu J, Igarashi S, Sasaki M, Matsubara T, Yoneda N, Kozaka K, Ikeda H, Kim J, Yu E, Matsui O, Nakanuma Y. Liver Int; 2012 Aug; 32(7):1156-64. PubMed ID: 22417172 [Abstract] [Full Text] [Related]
42. Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT. Lee HM, Lu DS, Krasny RM, Busuttil R, Kadell B, Lucas J. AJR Am J Roentgenol; 1997 Jul; 169(1):125-30. PubMed ID: 9207511 [Abstract] [Full Text] [Related]
43. The CT appearances for differentiating of peripheral, mass-forming cholangiocarcinoma and liver meatastases from colorectal adenocarcinoma. Apisarnthanarak P, Pansri C, Maungsomboon K, Thamtorawat S. J Med Assoc Thai; 2014 Apr; 97(4):415-22. PubMed ID: 24964684 [Abstract] [Full Text] [Related]
44. The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma. Han J, Liu Y, Han F, Li Q, Yan C, Zheng W, Wang J, Guo Z, Wang J, Li A, Zhou J. Ultrasound Med Biol; 2015 Dec; 41(12):3088-95. PubMed ID: 26386477 [Abstract] [Full Text] [Related]
45. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound. Chen LD, Ruan SM, Liang JY, Yang Z, Shen SL, Huang Y, Li W, Wang Z, Xie XY, Lu MD, Kuang M, Wang W. World J Gastroenterol; 2018 Sep 07; 24(33):3786-3798. PubMed ID: 30197484 [Abstract] [Full Text] [Related]
46. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma. Bohle W, Clemens PU, Heubach T, Zoller WG. Ultraschall Med; 2012 Dec 07; 33(7):E191-E195. PubMed ID: 22194045 [Abstract] [Full Text] [Related]
47. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT. Byun JH, Kim TK, Lee CW, Lee JK, Kim AY, Kim PN, Ha HK, Lee MG. Radiology; 2004 Aug 07; 232(2):354-60. PubMed ID: 15215556 [Abstract] [Full Text] [Related]
48. Small hypervascular enhancing lesions on arterial phase images of multiphase dynamic computed tomography in cirrhotic liver: fate and implications. Hwang SH, Yu JS, Kim KW, Kim JH, Chung JJ. J Comput Assist Tomogr; 2008 Aug 07; 32(1):39-45. PubMed ID: 18303286 [Abstract] [Full Text] [Related]
50. Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound. Wang ZL, Tang J, Weskott HP, Li JL, Wang W, Luo YK, An LC, Xu JH. J Gastroenterol Hepatol; 2008 Oct 07; 23(10):1511-9. PubMed ID: 18713302 [Abstract] [Full Text] [Related]
51. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI. Hwang J, Kim YK, Park MJ, Lee MH, Kim SH, Lee WJ, Rhim HC. J Magn Reson Imaging; 2012 Oct 07; 36(4):881-9. PubMed ID: 22730271 [Abstract] [Full Text] [Related]
52. Liver tumor characterization--review of the literature. Dietrich CF, Maddalena ME, Cui XW, Schreiber-Dietrich D, Ignee A. Ultraschall Med; 2012 Jul 07; 33 Suppl 1():S3-10. PubMed ID: 22723026 [Abstract] [Full Text] [Related]
53. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Asayama Y, Yoshimitsu K, Irie H, Tajima T, Nishie A, Hirakawa M, Nakayama T, Kakihara D, Taketomi A, Aishima S, Honda H. Radiology; 2006 Jan 07; 238(1):150-5. PubMed ID: 16304089 [Abstract] [Full Text] [Related]
54. Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging. D'Onofrio M, Vecchiato F, Cantisani V, Barbi E, Passamonti M, Ricci P, Malagò R, Faccioli N, Zamboni G, Pozzi Mucelli R. Radiol Med; 2008 Feb 07; 113(1):76-86. PubMed ID: 18338129 [Abstract] [Full Text] [Related]
55. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, Bruix J. Hepatology; 2009 Sep 07; 50(3):791-8. PubMed ID: 19610049 [Abstract] [Full Text] [Related]
56. Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features. Fukukura Y, Taguchi J, Nakashima O, Wada Y, Kojiro M. J Comput Assist Tomogr; 1997 Sep 07; 21(1):52-8. PubMed ID: 9022770 [Abstract] [Full Text] [Related]
57. Non-invasive diagnosis of small nodules in cirrhosis. Fujita T. J Hepatol; 2013 Dec 07; 59(6):1360-1. PubMed ID: 23958936 [No Abstract] [Full Text] [Related]
58. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. Ippolito D, Sironi S, Pozzi M, Antolini L, Ratti L, Alberzoni C, Leone EB, Meloni F, Valsecchi MG, Fazio F. Acad Radiol; 2008 Jul 07; 15(7):919-27. PubMed ID: 18572129 [Abstract] [Full Text] [Related]
60. Detection and characterization of hepatocellular carcinoma: value of dynamic CT during the arterial dominant phase with uniphasic contrast medium injection. Cho JS, Kwag JG, Oh YR, Han SD, Song CJ. J Comput Assist Tomogr; 1996 Jul 07; 20(1):128-34. PubMed ID: 8576463 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]